Table 5.
The Proportion of Adverse events of All Years in School-Aged Children During Two Rounds of IPTsc Treatment Using Passive and Active Surveillance.
| Treatment Arms | ||||||||
|---|---|---|---|---|---|---|---|---|
| Adverse Events | SP + AS | AQ + AS | Control | |||||
| n | (%) | p-Value | n | (%) | p-Value | n | (%) | |
| Fever | 25 | 1.2 | 0.001 | 53 | 2.5 | 0.77 | 54 | 2.7 |
| Headache | 54 | 2.6 | 0.04 | 79 | 3.8 | 0.97 | 77 | 3.8 |
| Vomiting | 24 | 1.2 | 0.15 | 35 | 1.7 | 0.89 | 35 | 1.7 |
| Abdominal pain | 5 | 1.3 | 0.08 | 14 | 1.7 | 0.45 | 12 | 2.0 |
| Coughing | 28 | 1.4 | <0.001 | 5 | 0.2 | 0.42 | 9 | 0.5 |
| Diarrhea | 5 | 0.3 | 0.12 | 14 | 0.7 | 0.72 | 12 | 0.6 |
| Pruritis | 2 | 0.1 | 1 | 2 | 0.1 | 1 | 1 | 0.05 |
| Lethargic | 0 | 0 | - | 1 | 0.04 | - | 0 | 0 |
| Convulsion | 0 | 0 | - | 0 | 0 | - | 0 | 0 |
Comparison of the number of adverse events by all years and study treatment arms. The test statistic (p-value) calculated by the Chi-square test and Fisher’s Exact test, comparing the intervention arms to the control arm.